NCT05108597View on ClinicalTrials.gov

Effect of Rectal Misoprostol in Reducing Intra-operative Blood Loss During Myomectomy

PHASE3CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

March 4, 2019

Primary Completion Date

March 4, 2020

Study Completion Date

March 4, 2020

Conditions

Blood Loss, SurgicalUterine Myoma

Interventions

DRUG

Misoprostol

400ug misoprostol will be administered through rectal route, 1 hour before surgery to assess its effect on intra-operative blood loss during myomectomy

Trial Locations (1)

46000

PEMH, Rawalpindi

All Listed Sponsors

lead

Pak Emirates Military Hospital

OTHER

NCT05108597 - Effect of Rectal Misoprostol in Reducing Intra-operative Blood Loss During Myomectomy | Biotech Hunter | Biotech Hunter